RESUMO
Matrix metalloproteinases (MMPs), or matrixins, are a family of zinc endopeptidases that play a key role in both physiological and pathological tissue degradation. Normally, there is a careful balance between cell division, matrix synthesis and matrix degradation, which is under the control of cytokines, growth factors and cell matrix interactions. The MMPs are involved in remodelling during tissue morphogenesis and wound healing. Under pathological conditions, this balance is altered: in arthritis, there is uncontrolled destruction of cartilage; in cancer, increased matrix turnover is thought to promote tumour cell invasion. The demonstration of a functional role of MMPs in arthritis and tumour metastasis raises the possibility of therapeutic intervention using synthetic MMP inhibitors with appropriate selectivity and pharmacokinetics. As the process of drug discovery focuses on structure-based design, efforts to resolve the 3-dimensional structures of the MMP family have intensified. Several novel MMP inhibitors have been identified and are currently being investigated in clinical trials. The structural information that is rapidly accumulating will be useful in refining the available inhibitors to selectively target specific MMP family members. In this review, we focus on the role of MMPs and their inhibitors in tumour invasion, metastasis and angiogenesis, and examine how MMPs may be targeted to prevent cancer progression.
Assuntos
Antineoplásicos/uso terapêutico , Matriz Extracelular/enzimologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Metaloendopeptidases/antagonistas & inibidores , Neoplasias/tratamento farmacológico , Neoplasias/enzimologia , Inibidores de Proteases/uso terapêutico , Animais , Antineoplásicos/farmacologia , Humanos , Metaloendopeptidases/biossíntese , Metaloendopeptidases/classificação , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/enzimologia , Inibidores de Proteases/farmacologia , Inibidor Tecidual de Metaloproteinase-2/uso terapêutico , Inibidor Tecidual de Metaloproteinase-3/uso terapêuticoAssuntos
Acetiltransferases/metabolismo , Neoplasias da Mama/metabolismo , Regulação Neoplásica da Expressão Gênica , Receptor ErbB-2/metabolismo , Fatores de Transcrição/metabolismo , Acetiltransferases/genética , Actinas/metabolismo , Neoplasias da Mama/genética , Feminino , Humanos , Imuno-Histoquímica , Análise de Sequência com Séries de Oligonucleotídeos , Receptor ErbB-2/genética , Fatores de Transcrição/genéticaRESUMO
We present the results of a combined experimental and numerical investigation into steady secondary vortex flows confined between two concentric right circular cylinders. When the flow is driven by the symmetric rotation of both end walls and the inner cylinder, toroidal vortex structures arise through the creation of stagnation points (in the meridional plane) at the inner bounding cylinder or on the mid-plane of symmetry. A detailed description of the flow regimes is presented, suggesting that a cascade of such vortices can be created. Experimental results are reported, which visualize some of the new states and confirm the prediction that they are stable to (mid-plane) symmetry-breaking perturbations. We also present some brief results for the flows driven by the rotation of a single end wall. Vortex structures may also be observed at low Reynolds numbers in this geometry. We show that standard flow visualization methods lead to some interesting non-axisymmetric particle paths in this case.
RESUMO
The bisphosphonates are a novel class of drug that have been registered for various clinical applications worldwide. Bisphosphonates, and in particular the aminobisphosphonates (nBPs), are known to have a number of side-effects including a rise in body temperature and accompanying flu-like symptoms that resemble a typical acute phase response. The mechanism for this response has been partially elucidated and appears to be associated with the release of tumour necrosis factor (TNF)alpha and interleukin (IL)6, although the effector cells that release these cytokines and the mechanism of action remain enigmatic. Here, we show that the nBP-induced acute phase response differs from the typical acute phase response in that CD14+ cells such as monocytes and macrophages are not the primary cytokine producing cells. We show that by inhibiting the mevalonate pathway, nBPs induce rapid and copious production of TNFalpha and IL6 by peripheral blood gammadelta T cells. Prior treatment with statins, which inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, blocks nBP-induced production of these proinflammatory cytokines by gammadelta T cells and may offer a means of avoiding the associated acute phase response. In addition, our findings provide a further mechanism for the anti-inflammatory effects attributed to inhibitors of HMG CoA reductase.
Assuntos
Reação de Fase Aguda/imunologia , Anticolesterolemiantes/imunologia , Citocinas/biossíntese , Difosfonatos/imunologia , Naftalenos/imunologia , Linfócitos T/imunologia , Citocinas/imunologia , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/imunologia , Interleucina-6/biossíntese , Interleucina-6/imunologia , Receptores de Lipopolissacarídeos/imunologia , Macrófagos/imunologia , Ácido Mevalônico/imunologia , Ácido Mevalônico/metabolismo , Monócitos/imunologia , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/imunologiaRESUMO
In colorectal cancer an association has been found between lack of epithelial basement membrane (EMB) immunostaining in the tumour centre and more extensive malignant spread. Interestingly, ultrastructural investigations suggest that EBM loss at the tumour periphery may be part of an invasive mechanism. To further assess the significance of EBM deficiencies in different tumour areas, we carried out a detailed study of the basement membrane laminin immunostaining patterns in 130 cases of colorectal carcinoma. We find that discontinuous EBM staining in the tumour centre is associated with poor tumour differentiation (p less than 0.005), presence of lymph-node metastases (p less than 0.02), and more advanced Dukes stage (p less than 0.02). The latter association is strengthened by excluding cases in which numerous polymorphonuclear leukocytes (PMNs) are present adjacent to EBM breaks, suggesting that these inflammatory cells are a confounding factor. Discontinuous EBM staining is more frequently observed in tumour deep to muscularis propria than in submucosal tumour (p less than 0.02), indicating intra-tumoral variation. At the tumour periphery, extensive EBM discontinuity shows no association with lymph-node involvement, but is linked with deeper local invasion (p less than 0.05). While EBM staining patterns around central and peripheral tumour glands are related (p less than 0.001), staining around peripheral glands is almost invariably more discontinuous. However, EBM lack at the tumour periphery is not as absolute as previously suggested, since in 18% of tumours fewer than 25% of peripheral tumour glands show EBM breaks. This appears consistent with the hypothesis that invasive changes at the tumour periphery are temporary and reversible.
Assuntos
Neoplasias do Colo/patologia , Neoplasias Retais/patologia , Membrana Basal/patologia , Neoplasias do Colo/cirurgia , Epitélio/patologia , Humanos , Laminina/análise , Metástase Linfática , Invasividade Neoplásica , Neoplasias Retais/cirurgia , Coloração e RotulagemRESUMO
Previous studies on colorectal carcinomas indicate that consistent differences in epithelial basement membrane (EBM) integrity are present between the tumour centre and periphery. We report that within the tumour centre, EBM staining between back-to-back (BTB) neoplastic glands (i.e., adjacent glands in direct contact with no intervening connective tissue) generally follows a pattern different from that of EBM staining at the tumour:stromal interface (TSI). Such distinctions are important, since the factors responsible for EBM deficiencies may vary with intra-tumoural location, as may the prognostic significance of these deficiencies. Analysis of paraffin sections from 130 colorectal carcinoma cases showed that EBM staining between BTB glands is generally weaker and more discontinuous than at the TSI, sometimes appearing as a linear array of immunostained granules on high-resolution light microscopy. By double-labelling immunofluorescence analysis of cryostat sections from 30 cases, a decrease in type-IV collagen:laminin staining intensity ratio was found between BTB glands. Hence, the composition of EBM between BTB glands appears to be abnormal. As much recent evidence indicates that epithelial:mesenchymal interactions play an essential role in EBM formation, the demonstration of immunostained EBM fragments between BTB glands requires an explanation: We suggest that the synthesis of EBM between BTB glands involved previously intervening stromal (mesenchymal) cells, and that EBM fusion and dissolution occur between BTB glands following the displacement of these cells.
Assuntos
Membrana Basal/ultraestrutura , Carcinoma/ultraestrutura , Neoplasias Colorretais/ultraestrutura , Membrana Basal/metabolismo , Carcinoma/metabolismo , Colágeno/metabolismo , Neoplasias Colorretais/metabolismo , Imunofluorescência , Humanos , Técnicas Imunoenzimáticas , Laminina/metabolismo , Fusão de MembranaRESUMO
Some invasive tumours characteristically have an abundant stroma rich in collagen, the production of which is termed the desmoplastic response. It has been suggested that this response may have a protective effect, and act to limit the process of tumour invasion. To investigate this possibility, we have examined various colorectal tumours for inter- and intra-tumoural variations in the desmoplastic response. As markers of this response, the distributions of collagen-I protein and myofibroblasts have been demonstrated by immunocytochemistry, while collagen-I messenger RNA has been demonstrated by in situ hybridization (ISH). Evidence of a desmoplastic response was obvious in carcinomas, but not in non-invasive adenomas. In carcinomas, we found that the response was marked in the tumour centre, where morphological features of active invasion have been reported to be absent. By contrast, we found little evidence of a desmoplastic response at the invasive edge of these carcinomas, where features suggestive of active invasion are prominent: in this location, collagen-I immunostaining was limited and myofibroblasts were sparsely distributed or absent. While our ISH results suggested active collagen-I synthesis in the tumour centre, there was little evidence of collagen-I synthesis in host tissues ahead of the invasion front. On the basis of these and other reported findings, we suggest that, while the desmoplastic response may reduce the invasive activity of neoplastic cells in the tumour centre, it fails to prevent the spread of colorectal cancer because of its deficiency at the invasive edge.
Assuntos
Carcinoma/química , Colágeno/análise , Neoplasias Colorretais/química , Carcinoma/patologia , Neoplasias Colorretais/patologia , Tecido Conjuntivo/química , Desmina/análise , Fibroblastos/química , Humanos , Hibridização In Situ , Invasividade Neoplásica , RNA Mensageiro/análise , RNA Neoplásico/análise , Coloração e RotulagemRESUMO
Genetic changes occurring in the late stages of colonic tumour progression have received much less attention than those occurring in the early stages. As described in the accompanying paper, SW480 and SW620 cell lines provide a useful model for studying the advanced stages of progression for colon cancer. Comparison of the two cell lines by differential display reveals that SW620 cells express lower levels of the CC3 tumour suppressor gene and also lower levels of the tissue inhibitor of metalloproteinases-3 (TIMP-3) gene. Northern blot analysis for TIMP-3 confirms this finding and shows a similar difference in the expression of TIMP-2, which seems logical since TIMPs inhibit enzymes that play a role in tumour invasion. For this reason, it was surprising to find that TIMP-1 messenger RNA expression is markedly increased in SW620 cells. Consistent with this finding, western blot analysis shows a ten-fold increase in TIMP-1 protein secretion by SW620 cells. It is noteworthy that high TIMP-1 expression is associated with poor prognosis in colorectal cancer. This association between TIMP-1 expression and tumour progression may be related to additional growth factor-like effects described for TIMP-1 in some systems.
Assuntos
Neoplasias do Colo/metabolismo , Proteínas de Neoplasias/metabolismo , Inibidores de Proteases/metabolismo , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Northern Blotting , Western Blotting , Neoplasias do Colo/patologia , Progressão da Doença , Expressão Gênica , Humanos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/genética , Inibidor Tecidual de Metaloproteinase-1/genética , Inibidor Tecidual de Metaloproteinase-2/genética , Inibidor Tecidual de Metaloproteinase-2/metabolismo , Inibidor Tecidual de Metaloproteinase-3/genética , Inibidor Tecidual de Metaloproteinase-3/metabolismo , Células Tumorais CultivadasRESUMO
Remodeling of the extracellular matrix (ECM), which occurs during many physiological and pathological processes, is one of the requisite events of cellular invasion. The matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases that are responsible for proteolytic degradation of specific ECM components. Regulating the activity of the MMPs at both mRNA and/or protein levels modulates the degradation of the ECM components which in turn alter cellular invasion. Although most MMPs are regulated via similar mechanisms at the mRNA and protein levels, the modulation of gelatinase A is unique. Understanding the mechanisms that regulate gelatinase A is important since expression and activation of this particular MMP is consistently correlated with a majority of malignant phenotypes. In this report, we will contrast the mechanisms that regulate the expression, activation and inhibition of gelatinase A with the mechanisms that modulate the rest the MMP family.
Assuntos
Gelatinases/biossíntese , Metaloendopeptidases/biossíntese , Animais , Sítios de Ligação , Ativação Enzimática , Precursores Enzimáticos/metabolismo , Matriz Extracelular/enzimologia , Gelatinases/antagonistas & inibidores , Gelatinases/metabolismo , Glicoproteínas/farmacologia , Humanos , Metaloproteinase 2 da Matriz , Metaloendopeptidases/antagonistas & inibidores , Metaloendopeptidases/metabolismo , Inibidores de Proteases/farmacologia , Proteínas/farmacologia , Inibidor Tecidual de Metaloproteinase-2 , Inibidores Teciduais de Metaloproteinases , Transcrição GênicaRESUMO
Extracellular matrix (ECM) turnover is an event that is tightly regulated. Much of the coordinate (physiological) or discoordinate (pathological) degradation of the ECM is catalyzed by a class of proteases known as the matrix metalloproteinases (MMPs) or matrixins. Matrixins are a family of homologous Zn atom dependent endopeptidases that are usually secreted from cells as inactive zymogens. Net degradative activity in the extracellular environment is regulated by specific activators and inhibitors. One member of the matrixin family, gelatinase A, is regulated differently from other MMPs, suggesting that it may play a unique role in cell-matrix interactions, including cell invasion. The conversion from the 72 kDa progelatinase A to the active 62 kDa species may be a key event in the acquisition of invasive potential. This discussion reviews some recent findings on the cellular mechanisms involved in progelatinase A activation and, in particular, the role of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) and transmembrane containing metalloproteinases (MT-MMP) in this process.
Assuntos
Matriz Extracelular/fisiologia , Gelatinases/fisiologia , Metaloendopeptidases/fisiologia , Proteínas/fisiologia , Sequência de Aminoácidos , Animais , Gelatinases/genética , Regulação Enzimológica da Expressão Gênica , Humanos , Metaloproteinase 2 da Matriz , Metaloendopeptidases/genética , Invasividade Neoplásica , Neoplasias/enzimologia , Neoplasias/patologia , Inibidor Tecidual de Metaloproteinase-2RESUMO
For tumours to grow they must acquire an adequate blood supply, and the use of drugs to inhibit tumour vascularization is one promising approach to anti-cancer therapy. Clear information is therefore required on the vascular architecture of human tumours and animal tumour models used for testing anti-angiogenic therapies. Many previous studies on animal tumour models have shown that carcinomas are least vascular in their centres and that host tissues become more vascular with proximity to the tumour. However, we have previously found that many human colorectal carcinomas do not show this pattern. The present study on human oral squamous cell carcinomas (SCCs) again reveals significant differences. Paraffin sections from 24 SCCs were immunostained using the QBEnd-10 monoclonal antibody to demonstrate blood vessels, and these were quantified by interactive morphometry using a Kontron Videoplan system. In most carcinomas, viable tumour tissue was no less vascular in the tumour centre than in the tumour periphery. Although tumours are known to release angiogenic factors, viable tumour tissue was less vascular than adjacent host tissues. However, the tumour stroma, by itself, was more vascular than adjacent host tissues. Host tissue adjacent to tumour showed no obvious increase in vascular density with increasing proximity to the tumour edge, which suggests that tumour-released angiogenic factors are only effective over a short distance.
Assuntos
Carcinoma de Células Escamosas/irrigação sanguínea , Tecido Conjuntivo/irrigação sanguínea , Neoplasias Bucais/irrigação sanguínea , Neovascularização Patológica/patologia , HumanosRESUMO
For colorectal carcinomas, there is evidence that marked discontinuity of the epithelial basement membrane (EBM) is associated with higher malignant potential. Since the metastatic process appears to be selective, more discontinuous EBMs might be expected in secondary rather than in primary tumours. To test this prediction, we examined a series of 60 cases of colorectal carcinoma for which samples of lymph-node or liver metastases were available. Sections were immunocytochemically stained for laminin, and the continuity of tumour EBM was then assessed by observational rating as well as by detailed morphometric analysis for a sample of cases. Contrary to the above prediction, we find that EBMs tend to be more continuous in secondary tumours than in corresponding primary tumours. These results could be explained by the possibility that local tissue environmental factors have a major influence on EBM continuity. Supporting evidence comes from our previous observation that EBM is very discontinuous at the advancing edge of primary colorectal carcinomas, where the tumour is adjacent to collagen-I-deficient stroma. Further evidence from the present study is that the EBM is extremely discontinuous at the interface between metastases and specialised parechymal tissue, but more continuous at the interface between metastases and stromal connective tissue. Since basement membranes affect the differentiation and behaviour of adjacent cells, these findings suggest that host tissue may influence invasive activity through their effects on EBM continuity.
Assuntos
Membrana Basal/patologia , Carcinoma/patologia , Neoplasias Colorretais/patologia , Humanos , Neoplasias Hepáticas/secundário , Metástase Linfática/patologia , Metástase Neoplásica/patologia , Reprodutibilidade dos TestesRESUMO
Qualitative histological studies in the distribution of urokinase-type plasminogen activator (uPA) in human colorectal carcinomas have been well documented. However, to our knowledge the histological distribution of this enzyme has not been quantified in any tumour. For the present image analysis study, uPA was demonstrated in sections of human colorectal cancer using immunoperoxidase technique. A total of 9 colorectal carcinoma cases were used, in which 132 regions were analysed. Within each region, staining intensity measurements were made at evenly spaced intervals. Samples of normal mucosa from 6 cases were also studied. Enzyme levels were assessed with staining intensity measurements. For each section, a negative control section was included, in which the primary antibody was omitted. Staining for uPA was quantified for each region in the test section, and the measurement for the corresponding region of the negative control was then subtracted. The enzyme uPA was localised more at the tumour edge than in the tumour centre or distant host tissue. These differences were highly significant (p < 0.0001). There was also a highly significant difference in staining intensity when tumour regions adjacent to pushing edge were compared with those adjacent to infiltrating edge (p < 0.0001). Infiltrating tumours showed stronger staining for uPA than tumours with pushing edges. Since invasive activity is thought to be maximal at the edge of the tumour, localisation of uPA at this site is consistent with the role of this enzyme in the process of tumour invasion.
Assuntos
Adenocarcinoma/enzimologia , Neoplasias Colorretais/enzimologia , Ativador de Plasminogênio Tipo Uroquinase/metabolismo , Adenocarcinoma/patologia , Membrana Basal/patologia , Colágeno/metabolismo , Neoplasias Colorretais/patologia , Humanos , Processamento de Imagem Assistida por Computador , Invasividade NeoplásicaRESUMO
A tumour-specific polypeptide designated U90 is one of a set of polypeptides which are encoded by the host cell and are specific for the transformed cell state, being immunoprecipitated by the sera of tumour-bearing animals. The interest in these tumour-specific polypeptides centres on the finding that they are also recognized by antisera raised against herpes simplex virus type 2 (HSV-2)-infected cells, implying some role for HSV-2 in tumorigenesis. The peptide map of HSV-2-induced U90 is indistinguishable from that of U90 present in uninfected tumour cells, including mouse cells transformed by human papillomavirus type 16. In tumour cells, U90 is located principally in the plasma membrane fraction and cannot be induced by heat shock, glucose starvation, or treatment with tunicamycin or calcium ionophore. U90 is not related to either the heat shock protein of Mr 90,000 (HSP90) or the glucose-related polypeptide of Mr 94,000 (GRP94) as determined by peptide mapping and the use of monospecific, monoclonal and antipeptide antibodies. This suggests that U90 is a novel transformation-specific protein which can be induced by infection with HSV-2.
Assuntos
Biossíntese Peptídica , Simplexvirus/fisiologia , Animais , Autorradiografia , Linhagem Celular Transformada/metabolismo , Eletroforese em Gel de Poliacrilamida , Proteínas de Choque Térmico/biossíntese , Testes de Precipitina , Ensaio de Radioimunoprecipitação , RatosRESUMO
Increased collagenase activity in colorectal carcinomas has recently been shown to be associated with increased malignant potential. To determine the tissue distribution of collagenase and its specific inhibitor, tissue inhibitor of metalloproteinases (TIMP), we carried out an immunohistochemical study on colorectal carcinomas (n = 20), adenomas (n = 7) and normal mucosa (n = 6). We found increased staining for collagenase in the connective tissue stroma of carcinomas, as compared with adenomas and normal mucosa. Little evidence of epithelial cell staining for collagenase was seen in any tissue. In carcinomas, both stromal fibroblasts and collagen fibres stained strongly and stromal staining was strongest close to neoplastic glands. Vascular staining was more prominent in neoplastic than normal tissues, perhaps reflecting the increased proteolytic activity during tumour angiogenesis. The pattern of TIMP immunostaining was similar to that of collagenase, although basement membrane staining for TIMP was generally more intense. Another difference was that, unlike TIMP, staining for collagenase was often increased at the invasive edge of carcinomas, perhaps reflecting increased collagenase activity at this location.
Assuntos
Adenoma/enzimologia , Neoplasias Colorretais/enzimologia , Glicoproteínas/análise , Colagenase Microbiana/análise , Membrana Basal/enzimologia , Tecido Conjuntivo/enzimologia , Epitélio/enzimologia , Humanos , Técnicas Imunoenzimáticas , Mucosa Intestinal/enzimologia , Distribuição Tecidual , Inibidores Teciduais de MetaloproteinasesRESUMO
Many studies suggest that increased proteolysis accounts for the epithelial basement membrane (EBM) breaks commonly seen in carcinomas. As failure to produce or maintain EBM may also be important, we chose to investigate synthesis of basement membrane collagen-IV in human colorectal carcinomas. First, to determine the cellular origin of EBM collagen-IV, species-specific antibodies were used to analyse caecal xenografts of 4 different human colorectal-carcinoma-derived cell lines. The results of this study suggest an exclusively stromal cell origin for EBM collagen-IV. Next, the distribution of periglandular myofibroblasts in carcinomas was examined, since in normal mucosa their location and ultrastructural features suggest that they play a role in EBM maintenance. They were generally abundant in normal mucosa and adenomas, but sparsely distributed in carcinomas, particularly at the invasive periphery where EBM collagen-IV immunostaining is most deficient. Finally, the in situ hybridization technique was used to define cell populations synthesizing collagen-IV. In normal mucosa, no collagen-IV mRNA was detected in any component, while in carcinomas, the mRNA was clearly detectable in vascular endothelial cells but not in any other cell type. Increased vascular collagen-IV production in carcinomas may be at least partly due to tumour-induced angiogenesis, since new blood-vessel formation requires the synthesis of new vascular basement membranes.
Assuntos
Adenoma/metabolismo , Carcinoma/metabolismo , Colágeno/biossíntese , Neoplasias Colorretais/metabolismo , Animais , Membrana Basal/metabolismo , Linhagem Celular , Colágeno/genética , Sondas de DNA , Humanos , Técnicas Imunoenzimáticas , Mucosa Intestinal/metabolismo , Camundongos , Camundongos Nus , Transplante de Neoplasias , Hibridização de Ácido Nucleico , RNA Mensageiro/análiseRESUMO
Anti-sera raised against HSV-2-infected cells (WI) and the sera of animals bearing tumours (TBS) to HSV-2 transformed cells contain antibodies to a set of tumour-specific cell-coded polypeptides. The specificity of these polypeptides for tumour cells is monitored by the ability of [35S]-L-methionine labelled proteins to be immunoprecipitated by these anti-sera, in contrast to control cells from which the polypeptides are not precipitated. The polypeptides which share an epitope and are co-precipitated are of MWs 90,000 (a doublet), 40,000 and 32,000. The upper 90,000-MW polypeptide (U90) is induced by HSV-2 infection. This communication deals with the 40,000-MW polypeptide which was shown to be immunoprecipitated by TBS and a monoclonal antibody (MAb) raised to the DNA-binding proteins of HSV-2-infected cells. Immunological and biochemical studies reveal that the 40,000-MW protein which is immunoprecipitated comprises more than one polypeptide, and that the proteins may need to interact to produce the peptide pattern specific for the tumour form of the immunoprecipitated 40,000-MW protein. WI antisera and TBS both recognise antigens specific for tumour cells in sections of cervical-carcinoma tissue. Sera from patients with cancer of the cervix contain antibodies to a cell-coded polypeptide of MW 40,000, which by peptide analysis is indistinguishable from the 40,000-MW polypeptide induced by HSV-2 infection and immunoprecipitated by WI and TBS.
Assuntos
Anticorpos Antineoplásicos/imunologia , Antígenos de Neoplasias/imunologia , Herpes Simples/fisiopatologia , Neoplasias do Colo do Útero/imunologia , Animais , Antígenos de Neoplasias/biossíntese , Antígenos de Neoplasias/química , Feminino , Regulação Viral da Expressão Gênica , Humanos , Substâncias Macromoleculares , Peso Molecular , Fosfoproteínas/imunologia , Testes de Precipitina , Ratos , Ribonucleases/farmacologia , Simplexvirus/genéticaRESUMO
Many previous qualitative studies have shown that tumours are less vascular in the centre, and that host tissues become more vascular in close proximity to tumours. However, quantitative findings presented here for human colorectal cancer reveal some significant differences. Sections from 20 colorectal carcinomas (ten moderately and ten poorly differentiated) were immunostained with the QB/end/10 monoclonal to demonstrate blood vessels. These were measured by interactive morphometry and vascular volume density, surface density (Sv) and length density were recorded. In poorly differentiated carcinomas, the tumour centre was significantly less vascular than the periphery for all three parameters (P = 0.008 for Sv). However, no significant difference was seen for moderately differentiated tumours, which constitute the majority of colorectal cancers. Surrounding host tissues did not show a general increase in vascular density close to tumours. Furthermore, when total viable tissue was considered, the vascular density of carcinomas was not markedly different from normal mucosa. In the centre of moderately differentiated carcinomas for example, the mean value for Sv was only 1.4 times higher than the mean value for normal mucosa. These findings suggest that colorectal cancers may elicit a relatively weak angiogenic response, consistent with their exceptionally slow growth rate.
Assuntos
Neoplasias Colorretais/irrigação sanguínea , Neovascularização Patológica , Animais , Anticorpos Monoclonais , Colo/irrigação sanguínea , Neoplasias Colorretais/patologia , Tecido Conjuntivo/irrigação sanguínea , Humanos , Mucosa Intestinal/irrigação sanguínea , Coloração e Rotulagem/métodosRESUMO
There have been reports that squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) are surrounded by continuous epithelial basement membranes (EBMs). This argues against the hypothesis that EBM breaks are required for tumour invasion. We have used morphometric techniques to re-examine the evidence for SCCs and BCCs as objectively as possible. We assessed sections stained for type-IV collagen from 12 SCCs, 14 keratoacanthomas (KAs), 9 morphoeic BCCs, 10 nodular BCCs and 7 superficial multifocal BCCs. In the centre of these tumours, the EBM was generally more continuous than at the periphery, and this difference was statistically significant for SCCs, KAs and morphoeic BCCs (p < 0.01 in all). By considering central and peripheral tumour regions separately, a significant difference was seen between SCCs and the difficult to distinguish benign tumour KA. In the centre of the KAs, EBM was significantly more continuous than than in SCCs (p = 0.0029), which may suggest new ways of distinguishing these lesions. All of the SCCs and morphoeic BCCs examined showed clear evidence of EBM breaks, but some nodular BCCs did not. As nodular BCCs show an expansile growth pattern without typical histological features of tumour invasion, we suggest that these tumours may be at a pre-malignant stage. In general, our findings are consistent with the hypothesis that EBM breaks are required for tumour invasion.
Assuntos
Membrana Basal/ultraestrutura , Carcinoma Basocelular/ultraestrutura , Carcinoma de Células Escamosas/ultraestrutura , Neoplasias Cutâneas/ultraestrutura , Colágeno/metabolismo , Humanos , Técnicas ImunoenzimáticasRESUMO
SUMMARY It is becoming apparent that gamma delta T cells form an important part of the adaptive immune response. However, the ligands recognized by gamma delta T cell receptors (TCRs) and the exact biological function of the cells that express this receptor remain unclear. Numerous studies have shown that the dominant human peripheral blood subset of gamma delta T cells, which express a V gamma 9V delta 2 TCR, can activate in response to low molecular weight nonpeptidic molecules. Some of these components have been purified from bacteria or parasites. We examined the activation of polyclonal gamma delta T cell lines, clones with V gamma 9V delta 2 and V gamma 9V delta 1 TCRs, and gamma delta T cells directly ex vivo in response to multiple phosphate, alkylamine and aminobisphosphonate (nBP) antigens and purified protein derivative from Mycobacterium tuberculosis (PPD). V gamma 9V delta 2 T cells were able to respond to multiple small organic molecules of highly variable structure whereas cells expressing a similar V gamma 9 chain paired with a V delta 1 chain failed to recognize these antigens. Thus, the TCR delta chain appears to make an important contribution to the recognition of these antigens. The kinetics of responses to alkylphosphate and alkylamine antigens differ from those of responses to the nBP pamidronate. These different classes of antigen are believed to have differed mechanisms of action. Such differences explain why nBPs can be pulsed onto antigen presenting cells (APCs) and still retain their ability to activate gamma delta T cells while alkylphosphate and alkylamine antigens cannot. We also demonstrate that a substantial proportion of the cells that produce IFN gamma directly ex vivo in response to PPD are gamma delta T cells and that gamma delta T cell activation requires contact with cells of human origin.